Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms

Integrative Cancer Therapies
William J M HrusheskyDonald Braun

Abstract

Life has evolved on this planet with regular daily spans of direct solar energy availability alternating with nocturnal spans of dark. Virtually every earth-borne life form has factored this circadian pattern into its biology to ensure the temporal coordination with its resonating environment, a task essential for its individual survival and that of its species. The first whole genome inspections of mutations in human colon and breast cancer have observed specific retained clock gene mutations. Single nucleotide polymorphisms within the genes of clock, clock-controlled, and melatonin pathways have been found to confer excess cancer risk or protection from cancer. Experimental studies have shown that specific core clock genes (Per2 and Per1) are tumor suppressors because their genetic absence doubles tumor numbers, and decreasing their expression in cancer cells doubles cancer growth rate, whereas their overexpression decreases cancer growth rate and diminishes tumor numbers. Experimental interference with circadian clock function increases cancer growth rate, and clinical circadian disruption is associated with higher cancer incidence, faster cancer progression, and shorter cancer patient survival. Patients with advanced lung c...Continue Reading

References

Aug 7, 1991·Journal of the National Cancer Institute·R SmaalandO D Laerum
Jan 1, 1991·Annals of the New York Academy of Sciences·A E Reinberg
Aug 1, 1991·Gastroenterology·K N BuchiN H Rubin
Jan 1, 1988·Pharmacology & Therapeutics·L E SchevingW J Hrushesky
Nov 1, 1988·European Journal of Cancer & Clinical Oncology·W T BellamyR T Dorr
Apr 5, 1985·Science·W J Hrushesky
Jul 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D N DanforthM E Lippman
Dec 12, 1980·Science·A J LewyS P Markey
May 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P M SilberfarbP Schnurr
Aug 28, 1998·Journal of Psychosomatic Research·J S Carpenter, M A Andrykowski
Oct 17, 1998·Journal of the National Cancer Institute·W J HrusheskyE Haus
Aug 19, 1999·Journal of Biological Rhythms·A J LewyR L Sack
Jun 22, 2000·Journal of the National Cancer Institute·S E SephtonD Spiegel
Oct 13, 2001·Science·S SahaB Vogelstein
Oct 18, 2001·Journal of the National Cancer Institute·S DavisR G Stevens
Oct 18, 2001·Journal of the National Cancer Institute·E S SchernhammerG A Colditz
Apr 19, 2002·Chronobiology International·Marie-Christine Mormont, Jim Waterhouse
Dec 20, 2002·Cancer·Marie-Christine Mormont, Francis Levi
May 2, 2003·Nature Reviews. Cancer·Loning Fu, Cheng Chi Lee
Jun 5, 2003·Journal of the National Cancer Institute·Eva S SchernhammerGraham A Colditz
Jul 11, 2003·Pathologie-biologie·Elisabeth FilipskiFrancis Lévi
Aug 23, 2003·Science·Takuya MatsuoHitoshi Okamura
Aug 30, 2003·Brain, Behavior, and Immunity·Sandra Sephton, David Spiegel
Sep 1, 1959·The Anatomical Record·L E SCHEVING
Jan 1, 2004·Molecular and Cellular Biology·Choogon LeeSteven M Reppert
Mar 30, 2004·The Oncologist·Tracey L Evans
Jun 26, 2004·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Elisabeth FilipskiFrancis Lévi
Mar 1, 1997·Archives of Gerontology and Geriatrics·I Haimov, P Lavie
Nov 3, 2004·Cancer Research·Elisabeth FilipskiLévi Francis
Nov 17, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Teresa G GrandaFrancis Lévi
Dec 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tien HoangDavid H Johnson
Feb 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Victoria Y GorbachevaMarina P Antoch
May 4, 2005·Breast Cancer Research and Treatment·Shaojin YouWilliam J M Hrushesky
Nov 3, 2005·British Journal of Cancer·R D LevinW J M Hrushesky
Jan 6, 2006·Chronobiology International·L PardiniJ-P Galmiche
Jan 26, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Yong ZhuPeter Boyle
Aug 25, 2006·Molecular Cancer Therapeutics·Patricia A WoodWilliam J M Hrushesky
Nov 11, 2006·International Journal of Cancer. Journal International Du Cancer·Yong ZhuTongzhang Zheng
Mar 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sigal GeryH Phillip Koeffler

❮ Previous
Next ❯

Citations

Apr 10, 2012·Journal of Cancer Survivorship : Research and Practice·Ann M BergerLynne Farr
Sep 21, 2013·Journal of the National Cancer Institute·Andrea M BarsevickUNKNOWN National Cancer Institute Clinical Trials Planning Meeting
May 31, 2014·PLoS Genetics·Angela RelógioChristine Sers
Jul 20, 2012·Molecular Medicine·Christos Savvidis, Michael Koutsilieris
Oct 26, 2011·World Journal of Gastroenterology : WJG·Chun-Qiu ChenMartin Storr
Apr 26, 2014·World Journal of Gastroenterology : WJG·Gianluigi MazzoccoliAda Piepoli
Mar 28, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Georg SeifertAndreas Voss
Dec 10, 2013·International Journal of Behavioral Medicine·Sara VargasRobert P DerHagopian
Dec 14, 2011·Cancer Investigation·Valerio PazienzaGianluigi Mazzoccoli
Jun 10, 2011·Journal of Pharmaceutical Sciences·Shigehiro OhdoAhmed Hamdan
Apr 3, 2013·Journal of Physiology, Paris·Diego A GolombekJuan J Chiesa
May 31, 2016·NPJ Parkinson's Disease·Joseph H FriedmanDaniel Weintraub
Jul 27, 2010·PM & R : the Journal of Injury, Function, and Rehabilitation·Sandra A Mitchell
Mar 10, 2016·Acta histochemica·S BurattiniS Salucci
Apr 11, 2012·International Journal of Cancer. Journal International Du Cancer·Pasquale F InnominatoFrancis A Lévi
Feb 11, 2014·International Journal of Cancer. Journal International Du Cancer·Elisabet Ortiz-TudelaPasquale F Innominato
Aug 9, 2015·Chinese Journal of Cancer·Abbas Salavaty
Aug 14, 2012·Brain, Behavior, and Immunity·Sandra E SephtonPaul Salmon
Jan 5, 2011·Colloids and Surfaces. B, Biointerfaces·S JoseE B Souto
Jul 23, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Olga GolubnitschajaGodfrey Grech
Oct 11, 2016·Trends in Neurosciences·Raymond van EeBjörn N S Vlaskamp
Feb 1, 2012·The Journal of International Medical Research·X-L HuangR-F Bu
Sep 26, 2013·Journal of Dental Research·S PapagerakisP Papagerakis
Dec 12, 2012·HERD·Maria Regina Clemesha Kennedy
Mar 22, 2013·Therapeutic Advances in Endocrinology and Metabolism·Ifigenia Kostoglou-Athanassiou
Oct 5, 2010·Cell Cycle·Carl Hirschie Johnson
Jun 11, 2019·Chronobiology International·Eliana RovedaPatrizia Pasanisi
Mar 30, 2017·Pharmacological Reviews·Annabelle BallestaFrancis A Lévi
Apr 26, 2020·Current Opinion in Supportive and Palliative Care·Elisa N HofmeisterPasquale F Innominato
Feb 13, 2018·Molecular and Clinical Oncology·Minou NirvaniAmer Sehic
Mar 9, 2011·Integrative Cancer Therapies·Judith K Payne
Sep 1, 2013·EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [et Al.]·Maria Die Trill

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.